These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 15279010)

  • 1. The impact of the Food and Drug Administration Modernization Act on the recruitment of children for research.
    Sharav VH
    Ethical Hum Sci Serv; 2003; 5(2):83-108. PubMed ID: 15279010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Children in clinical research: a conflict of moral values.
    Sharav VH
    Am J Bioeth; 2003; 3(1):W-IF 2. PubMed ID: 14560714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Best Pharmaceuticals for Children Act of 2002: the rise of the voluntary incentive structure and congressional refusal to require pediatric testing.
    Breslow LH
    Harvard J Legis; 2003; 40(1):133-93. PubMed ID: 16594116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantifying the federal minimal risk standard: implications for pediatric research without a prospect of direct benefit.
    Wendler D; Belsky L; Thompson KM; Emanuel EJ
    JAMA; 2005 Aug; 294(7):826-32. PubMed ID: 16106008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pediatric exclusivity: evolving legislation and novel complexities within pediatric therapeutic development.
    Rivera DR; Hartzema AG
    Ann Pharmacother; 2014 Mar; 48(3):369-79. PubMed ID: 24311725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current issues in clinical research and the development of new pharmaceuticals.
    Goldhammer A
    Account Res; 2001; 8(4):283-91. PubMed ID: 12481798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The ethics and science of medicating children.
    Sparks JA; Duncan BL
    Ethical Hum Psychol Psychiatry; 2004; 6(1):25-39. PubMed ID: 15706694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug development process for a product with a primary pediatric indication.
    Allen AJ; Michelson D
    J Clin Psychiatry; 2002; 63 Suppl 12():44-9. PubMed ID: 12562061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mental illness and addiction issue brief: psychotropic medication and children: year end report-2004.
    Rosenberg M
    Issue Brief Health Policy Track Serv; 2004 Dec; ():1-7. PubMed ID: 15744950
    [No Abstract]   [Full Text] [Related]  

  • 10. American Society of Clinical Oncology policy statement: oversight of clinical research.
    American Society of Clinical Oncology
    J Clin Oncol; 2003 Jun; 21(12):2377-86. PubMed ID: 12721281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pediatric research and the federal minimal risk standard.
    Ross LF; Nelson RM
    JAMA; 2006 Feb; 295(7):759; author reply 759-60. PubMed ID: 16478898
    [No Abstract]   [Full Text] [Related]  

  • 12. FDA's proposed regulations to expand access to investigational drugs for treatment use: the status quo in the guise of reform.
    Rossen BR
    Food Drug Law J; 2009; 64(1):183-223. PubMed ID: 19998746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Problems of drug testing in children in the United States.
    Yaffe SJ
    Pediatr Pharmacol (New York); 1983; 3(3-4):339-48. PubMed ID: 11659147
    [No Abstract]   [Full Text] [Related]  

  • 14. Medical studies and the average American kid.
    Weiss R
    Washington Post; 2005 Aug; ():A5. PubMed ID: 16138447
    [No Abstract]   [Full Text] [Related]  

  • 15. Stimulation programs for pediatric drug research--do children really benefit?
    Boots I; Sukhai RN; Klein RH; Holl RA; Wit JM; Cohen AF; Burggraaf J
    Eur J Pediatr; 2007 Aug; 166(8):849-55. PubMed ID: 17225950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Encouraging research and development of pediatric medical devices through legislative and regulatory action: the Pediatric Medical Device Safety and Improvement Act of 2007 in context.
    Bleicher EW
    Food Drug Law J; 2009; 64(3):531-64. PubMed ID: 19999642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Research with children.
    Glantz LH
    Am J Law Med; 1998; 24(2-3):213-44. PubMed ID: 9702273
    [No Abstract]   [Full Text] [Related]  

  • 18. Removal of regulations regarding certification of antibiotic drugs--FDA. Direct final rule.
    Fed Regist; 1998 May; 63(91):26066-9. PubMed ID: 10179333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Policy developments in regulatory approval.
    Temple R
    Stat Med; 2002 Oct; 21(19):2939-48. PubMed ID: 12325110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmaceuticals and medical devices: business practices.
    Steiner DJ
    Issue Brief Health Policy Track Serv; 2013 Dec; ():1-36. PubMed ID: 24482889
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.